113 related articles for article (PubMed ID: 28743492)
21. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
22. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition.
Varela AT; Simões AM; Teodoro JS; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
Mitochondrion; 2010 Aug; 10(5):456-63. PubMed ID: 20433952
[TBL] [Abstract][Full Text] [Related]
23. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
[TBL] [Abstract][Full Text] [Related]
24. Indirubin-3'-oxime inhibits inflammatory activation of rat brain microglia.
Jung HJ; Nam KN; Son MS; Kang H; Hong JW; Kim JW; Lee EH
Neurosci Lett; 2011 Jan; 487(2):139-43. PubMed ID: 20946938
[TBL] [Abstract][Full Text] [Related]
25. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.
Song JH; Lee JE; Cho KM; Park SH; Kim HJ; Kim YC; Kim TS
Mol Carcinog; 2016 May; 55(5):611-21. PubMed ID: 25788004
[TBL] [Abstract][Full Text] [Related]
26. An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.
Efstathiou A; Gaboriaud-Kolar N; Smirlis D; Myrianthopoulos V; Vougogiannopoulou K; Alexandratos A; Kritsanida M; Mikros E; Soteriadou K; Skaltsounis AL
Parasit Vectors; 2014 May; 7():234. PubMed ID: 24886176
[TBL] [Abstract][Full Text] [Related]
27. Indirubin-3'-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons.
Xie Y; Liu Y; Ma C; Yuan Z; Wang W; Zhu Z; Gao G; Liu X; Yuan H; Chen R; Huang S; Wang X; Zhu X; Wang X; Mao Z; Li M
Neurosci Lett; 2004 Sep; 367(3):355-9. PubMed ID: 15337265
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of polyfunctionalized piperidone oxime ethers and their cytotoxicity on HeLa cells.
Parthiban P; Pallela R; Kim SK; Park DH; Jeong YT
Bioorg Med Chem Lett; 2011 Nov; 21(22):6678-86. PubMed ID: 21983445
[TBL] [Abstract][Full Text] [Related]
29. A long-wavelength, fluorogenic probe for epoxide hydrolase: 7-(2-(oxiran-2-yl)ethoxy) resorufin.
Shen W; Zhang J; Mao G; Jiang K; Zhu Q
Biol Pharm Bull; 2009 Sep; 32(9):1496-9. PubMed ID: 19721221
[TBL] [Abstract][Full Text] [Related]
30. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
Scobie MR; Houke HR; Rice CD
Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
[TBL] [Abstract][Full Text] [Related]
31. Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim.
Thao NP; Luyen BT; Lee JS; Kim JH; Kim YH
Bioorg Med Chem Lett; 2017 Apr; 27(8):1874-1879. PubMed ID: 28279529
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
Karami L; Saboury AA; Rezaee E; Tabatabai SA
Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
[TBL] [Abstract][Full Text] [Related]
33. The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.
Tsakiri EN; Gaboriaud-Kolar N; Iliaki KK; Tchoumtchoua J; Papanagnou ED; Chatzigeorgiou S; Tallas KD; Mikros E; Halabalaki M; Skaltsounis AL; Trougakos IP
Antioxid Redox Signal; 2017 Nov; 27(14):1027-1047. PubMed ID: 28253732
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase.
Shou M; Gonzalez FJ; Gelboin HV
Biochemistry; 1996 Dec; 35(49):15807-13. PubMed ID: 8961944
[TBL] [Abstract][Full Text] [Related]
35. 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Ahn MY; Kim TH; Kwon SM; Yoon HE; Kim HS; Kim JI; Kim YC; Kang KW; Ahn SG; Yoon JH
Eur J Pharm Sci; 2015 Nov; 79():122-31. PubMed ID: 26342773
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
[TBL] [Abstract][Full Text] [Related]
37. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
Kosmopoulou MN; Leonidas DD; Chrysina ED; Bischler N; Eisenbrand G; Sakarellos CE; Pauptit R; Oikonomakos NG
Eur J Biochem; 2004 Jun; 271(11):2280-90. PubMed ID: 15153119
[TBL] [Abstract][Full Text] [Related]
38. Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.
Zhang B; Tan VB; Lim KM; Tay TE; Zhuang S
J Mol Model; 2007 Jan; 13(1):79-89. PubMed ID: 16770643
[TBL] [Abstract][Full Text] [Related]
39. Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.
Schepetkin IA; Plotnikov MB; Khlebnikov AI; Plotnikova TM; Quinn MT
Biomolecules; 2021 May; 11(6):. PubMed ID: 34067242
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activity.
Gulipalli KC; Bodige S; Ravula P; Endoori S; Vanaja GR; Suresh Babu G; Narendra Sharath Chandra JN; Seelam N
Bioorg Med Chem Lett; 2017 Aug; 27(15):3558-3564. PubMed ID: 28579122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
